Camptothecin/Podophyllotoxin

喜树碱/鬼臼毒素

Report date: 2026/05/14 20:00:28

Base Information

Drug NameCamptothecin/Podophyllotoxin
Drug Alias Name鬼臼毒素/喜树碱Camptothecin/Podofilox鬼臼毒素喜树碱Camptothecin and PodophyllotoxinPodofilox and Camptothecin +[10] 
ClassificationSmall molecules
Mechanisms of ActionTubulin polymerisation inhibitorsDNA topoisomerase I inhibitors
TargetsTubulinDNA topoisomerase I
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes CamptothecinPodofilox
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeovia Oncology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeovia Oncology Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A